Company Filing History:
Years Active: 2009-2015
Title: The Innovative Contributions of Lidia L Demchyshyn
Introduction
Lidia L Demchyshyn is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the area of GLP-2 receptor modulation. With a total of 5 patents to her name, her work has the potential to impact therapeutic approaches for various gastrointestinal conditions.
Latest Patents
One of her latest patents is an ex vivo method for determining potential GLP-2 receptor modulators. This innovative method involves measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Additionally, the patent discloses an assay that directly measures the activity of GLP-2 or GLP-2 ligands ex vivo, allowing for the screening of putative GLP-2 ligands in native tissue. This advancement could lead to new therapeutic options for patients suffering from related disorders.
Career Highlights
Lidia is currently employed at NPS Pharmaceuticals, Inc., where she continues to develop her research and innovations. Her work at this company has positioned her as a key player in the pharmaceutical industry, particularly in the realm of gastrointestinal health.
Collaborations
Lidia collaborates with various professionals in her field, including her coworker, Hong Wang. Their partnership exemplifies the importance of teamwork in driving innovation and advancing research in pharmaceuticals.
Conclusion
Lidia L Demchyshyn's contributions to the field of pharmaceuticals through her patents and research are commendable. Her innovative methods for GLP-2 receptor modulation hold promise for future therapeutic developments.